BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20425456)

  • 1. Late complications after treatment for Hodgkin lymphoma.
    Ng AK
    Curr Hematol Malig Rep; 2008 Jul; 3(3):119-25. PubMed ID: 20425456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.
    Darrington DL; Vose JM
    Curr Hematol Malig Rep; 2012 Sep; 7(3):200-7. PubMed ID: 22743837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance.
    Ng AK; van Leeuwen FE
    Semin Hematol; 2016 Jul; 53(3):209-15. PubMed ID: 27496313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma.
    Wang L; Zheng Y; Luo R; Kang K; Niedermann G; Zhao A; Wu Y
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):41. PubMed ID: 38280006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late effects of Hodgkin's disease and its treatment.
    Ng AK; Mauch PM
    Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
    van Leeuwen FE; Ng AK
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism.
    Kiserud CE; Seland M; Holte H; Fosså A; Fosså SD; Bollerslev J; Bjøro T; Loge JH
    Acta Oncol; 2015 Jan; 54(1):49-59. PubMed ID: 25140862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis.
    Lo AC; Chen B; Samuel V; Savage KJ; Freeman C; Goddard K
    J Cancer Surviv; 2021 Dec; 15(6):837-846. PubMed ID: 33453004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complications in Hodgkin's lymphoma survivors.
    Kilickap S; Barista I; Ulger S; Celik I; Selek U; Güllü I; Yildiz F; Kars A; Ozisik Y; Tekuzman G
    Tumori; 2012; 98(5):601-6. PubMed ID: 23235755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
    Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects.
    Ng AK
    Blood; 2014 Nov; 124(23):3373-9. PubMed ID: 25428219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the risk of therapy-associated complications in survivors of Hodgkin lymphoma.
    Travis LB
    Hematology Am Soc Hematol Educ Program; 2007; ():192-6. PubMed ID: 18024629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
    Majhail NS; Ness KK; Burns LJ; Sun CL; Carter A; Francisco L; Forman SJ; Bhatia S; Baker KS
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1153-9. PubMed ID: 17889351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton therapy for Hodgkin lymphoma.
    Rutenberg MS; Flampouri S; Hoppe BS
    Curr Hematol Malig Rep; 2014 Sep; 9(3):203-11. PubMed ID: 24842407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects.
    Ng AK
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):488-94. PubMed ID: 25696899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease. Treatment sequelae and quality of life.
    Henry-Amar M
    Baillieres Clin Haematol; 1996 Sep; 9(3):595-618. PubMed ID: 8922248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.
    Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H
    Pediatr Blood Cancer; 2007 Oct; 49(5):699-703. PubMed ID: 17420991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.